Pulmatrix Inc (PULM)

[riskon]

$PULM Short Term Catalysts (anytime now-Q1 2021)
1) PUR1900 FDA Type C Meeting -- likely bullish news coming out of there regarding P3 Trial Setup with Cipla -- perhaps even EUA but speculation only on such comment
2) PUR1900 new updated contract terms with CIPLA (more favorable to Pulmatrix assumed, likely retain US + Europe rights)
2) FEND New Studies/Data & Pathway to Global Launch -- India Manufacturing Pathway -- Potential Partnership with larger manufacturing partners/world organizations
3) PUR1800 Update with J&J - COPD Trials Start
4) Potential wildcard of JnJ inhaled vaccine development utilizing iSPERSE-- and/or other companies such as Pfizer/AstraZeneca (speculative comment yet foundation exists)
5) PUR3100 Migrane pre-clinical design update -- including who we are partnered with in such endeavor...
6) Nocion update of using iSPERSE on any of their portfolio
7) Unexpected partnerships/licensing deals either via therapeutic or vaccine(s) with iSPERSE enabled version